Skip to main content

Testicular Cancer clinical trials at UC Irvine

1 research study open to eligible people

Showing trials for
  • A Study of miRNA 371 in Patients With Germ Cell Tumors

    open to eligible people ages 18 years and up

    This trial studies whether the blood marker micro ribonucleic acid (miRNA) 371 can predict the chance of cancer returning in patients with germ cell cancers. Studying samples of blood from patients with germ cell cancers in the laboratory may help doctors predict how likely the cancer will come back.

    Orange, California and other locations

Last updated: